Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
Ludmilla de Plater(Centre National de la Recherche Scientifique), Elisabetta Marangoni(Institut Curie)
Cited by 44
Related Papers
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers
|Nature Communications|2023|96
Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancers
|Science Signaling|2017|52
Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts
|Molecular Cancer Therapeutics|2012|45